The Gut and Cervical Microbiome Promote Immune Activation and Response to Chemoradiation in Cervical Cancer

Lauren E. Colbert(The University of Texas MD Anderson Cancer Center), Ann H. Klopp(The University of Texas MD Anderson Cancer Center), Travis Solley(The University of Texas MD Anderson Cancer Center), Nadim J. Ajami(Baylor College of Medicine), Megan D. Mikkelson(The University of Texas MD Anderson Cancer Center), Joseph F. Petrosino(Baylor College of Medicine), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Anuja Jhingran(The University of Texas MD Anderson Cancer Center), Aradhana M. Venkatesan(National Institutes of Health), Patricia J. Eifel(The University of Texas MD Anderson Cancer Center), Andrea Y. Delgado Medrano(The University of Texas MD Anderson Cancer Center), Shane R. Stecklein(The University of Kansas Cancer Center), Lois M. Ramondetta(The University of Texas MD Anderson Cancer Center), R. Tyler Hillman(The University of Texas MD Anderson Cancer Center), Beth A. Helmink(The University of Texas MD Anderson Cancer Center), Cullen M. Taniguchi(The University of Texas MD Anderson Cancer Center), Kathleen M. Schmeler(The University of Texas MD Anderson Cancer Center), Pablo C. Okhuysen(The University of Texas MD Anderson Cancer Center), Michael Frumovitz(The University of Texas MD Anderson Cancer Center), Vancheswaran Gopalakrishnan(AstraZeneca (United States)), Stephanie Dorta‐Estremera(University of Houston), K. Jagannadha Sastry(University of Houston), Rebecca J. Previs(University of Houston), Andrew M. Futreal(Louisiana State University), Geena Mathew(University of Houston), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Stephen M. Hahn(The University of Texas MD Anderson Cancer Center), Diane Hutchinson(Baylor College of Medicine)
SSRN Electronic Journal
January 1, 2018
Cited by 4


Related Papers